{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:35:50Z","timestamp":1789659350854,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jctube.2025.100528","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:02:44Z","timestamp":1745582564000},"page":"100528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rifampicin-resistant Mycobacterium tuberculosis and unsuccessful results from Xpert\u00ae MTB\/Rif-Ultra assay in Amhara Region, Ethiopia"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-3705","authenticated-orcid":false,"given":"Gizeaddis","family":"Belay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailu","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigist","family":"Birku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimro","family":"Tadese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Gashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Getie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazeb","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molalign","family":"Tarekegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemayehu","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2025.100528_b0005","unstructured":"WHO. Global tuberculosis report. Geneva Switzerland; 2023."},{"key":"10.1016\/j.jctube.2025.100528_b0010","unstructured":"Dlodlo R, Brigden G, Heldal E, Allwood B, Chiang C, Fujiwara P, et al. Management of Tuberculosis: a Guide to Essential Practice. Paris, France: International Union Against Tuberculosis and Lung Disease, 2019. theunion org\/sites\/default\/files\/2020-08\/TheUnion_Orange_2019 pdf. 2021."},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-14-319","article-title":"Common types of tuberculosis and co-infection with HIV at private health institutions in Ethiopia: a cross sectional study","volume":"14","author":"Alemie","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jctube.2025.100528_b0020","unstructured":"Organization WH. Tuberculosis in the WHO African Region: 2023 progress update. Tuberculosis in the WHO African Region: 2023 progress update2023."},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","article-title":"Multidrug-resistant tuberculosis","volume":"10","author":"Dheda","year":"2024","journal-title":"Nat Rev Disease Primers"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","article-title":"Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019","volume":"24","author":"Lv","year":"2024","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.jctube.2025.100528_b0035","unstructured":"Organization WH. WHO releases new global lists of high-burden countries for TB, HIV-associated TB and drug-resistant TB. Geneva, Switzerland: WHO. 2021."},{"key":"10.1016\/j.jctube.2025.100528_b0040","first-page":"1","article-title":"Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome","volume":"4","author":"Girum","year":"2018","journal-title":"Trop Diseases Travel Med Vacc"},{"issue":"2","key":"10.1016\/j.jctube.2025.100528_b0045","article-title":"The burden of tuberculosis across regions in Ethiopia: a systematic subnational analysis for the global burden of disease study 2019","volume":"37","author":"Arja","year":"2023","journal-title":"Ethiopian J Health Development"},{"key":"10.1016\/j.jctube.2025.100528_b0050","doi-asserted-by":"crossref","unstructured":"Selfegna S, Alelign A. Detection of mycobacterium tuberculosis and rifampicin resistance using GeneXpert MTB\/RIF assay at Enat Hospital, Central Ethiopia. Tuberculosis Research and Treatment. 2022;2022.","DOI":"10.1155\/2022\/1250404"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12879-024-09135-0","article-title":"Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert\u00ae MTB\/RIF assay results from 2015 to 2021","volume":"24","author":"Biset","year":"2024","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.jctube.2025.100528_b0060","unstructured":"MoH-Ethiopia. National Comprehensive Tuberculosis, Leprosy and TB\/HIV Training Manual for Health Care Workers. Addis Ababa: Ministry of Health; 2018."},{"key":"10.1016\/j.jctube.2025.100528_b0065","first-page":"1","article-title":"The transition to Xpert MTB\/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda","volume":"21","author":"Andama","year":"2021","journal-title":"BMC Infect Diseases"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ajlm.v11i1.1811","article-title":"GeneXpert rollout in three high-burden tuberculosis countries in Africa: A review of pulmonary tuberculosis diagnosis and outcomes from 2001 to 2019","volume":"11","author":"Williams","year":"2022","journal-title":"African Journal of Laboratory Medicine"},{"key":"10.1016\/j.jctube.2025.100528_b0075","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","article-title":"Drug resistant TB\u2013latest developments in epidemiology, diagnostics and management","volume":"124","author":"Tiberi","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0080","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO's global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"The Lancet Microbe"},{"issue":"10","key":"10.1016\/j.jctube.2025.100528_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001271","article-title":"Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio","volume":"3","author":"Arinaminpathy","year":"2023","journal-title":"PLOS Global Public Health"},{"issue":"2","key":"10.1016\/j.jctube.2025.100528_b0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.33073\/pjm-2022-018","article-title":"Prevalence and drug resistance pattern of isolated from tuberculosis patients in Basra","volume":"71","author":"Mohammed","year":"2022","journal-title":"Iraq Polish Journal of Microbiology"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0095","first-page":"87","article-title":"The global tuberculosis report 2022: key data analysis for China and the global world","volume":"8","author":"Min","year":"2023","journal-title":"Electron J Emerg Infect Diseases"},{"issue":"4","key":"10.1016\/j.jctube.2025.100528_b0100","first-page":"368","article-title":"The global tuberculosis report 2021: key data analysis for China and the global world","volume":"6","author":"Chunrong","year":"2021","journal-title":"Electron J Emerg Infect Diseases"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Salari","year":"2023","journal-title":"Infectious Diseases of Poverty"},{"issue":"3","key":"10.1016\/j.jctube.2025.100528_b0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/microbiolres13030043","article-title":"Patterns of presentation of drug-resistant tuberculosis in nigeria: A retrospective file review","volume":"13","author":"Oladimeji","year":"2022","journal-title":"Microbiol Res"},{"key":"10.1016\/j.jctube.2025.100528_b0115","article-title":"Trends and characteristics of drug-resistant tuberculosis in rural Shandong","author":"Tao NingNing","year":"2017","journal-title":"China"},{"key":"10.1016\/j.jctube.2025.100528_b0120","doi-asserted-by":"crossref","unstructured":"Tao N-n, He X-c, Zhang X-x, Liu Y, Yu C-b, Li H-c. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China. Int J Infect Diseases. 2017;65:8-14.","DOI":"10.1016\/j.ijid.2017.09.019"},{"key":"10.1016\/j.jctube.2025.100528_b0125","doi-asserted-by":"crossref","first-page":"e3441","DOI":"10.1590\/1518.8345.4412.3441","article-title":"Impact of the GeneXpert\u00ae MTB\/RIF rapid molecular test on tuberculosis detection: temporal trends and vulnerable territories","volume":"29","author":"Berra","year":"2021","journal-title":"Rev Lat Am Enfermagem"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0130","article-title":"Molecular epidemiology of rifampicin resistance in Mycobacterium tuberculosis using the GeneXpert MTB\/RIF assay from a rural setting in India","volume":"2017","author":"Reddy","year":"2017","journal-title":"J Pathogens"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0135","first-page":"2","article-title":"Unsuccessful Xpert\u00ae MTB\/RIF results: the Nigerian experience","volume":"8","author":"Gidado","year":"2018","journal-title":"Public Healthaction"},{"issue":"11","key":"10.1016\/j.jctube.2025.100528_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225205","article-title":"Monitoring quality indicators for the Xpert MTB\/RIF molecular assay in Ethiopia","volume":"14","author":"Kebede","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/nmj.NMJ_12_19","article-title":"Assessment of GeneXpert MTB\/RIF performance by type and level of health-care facilities in Nigeria","volume":"60","author":"Gidado","year":"2019","journal-title":"Nigerian Medical Journal"},{"key":"10.1016\/j.jctube.2025.100528_b0150","unstructured":"GXMTB-ULTRA-MII R. Xpert\u00ae MTB\/RIF Ultra. 2019."},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0155","first-page":"31","article-title":"Trends of Xpert MTB\/RIF in the diagnosis of Mycobacterium tuberculosis and rifampicin resistance in Southwest Nigeria: A 4-year retrospective study","volume":"4","author":"Alao","year":"2022","journal-title":"J Pan African Thoracic Soc"},{"key":"10.1016\/j.jctube.2025.100528_b0160","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.2147\/IDR.S263023","article-title":"Rifampicin-resistant Mycobacterium tuberculosis among patients with presumptive tuberculosis in Addis Ababa","author":"Araya","year":"2020","journal-title":"Ethiopia Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40794-024-00224-1","article-title":"Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018-2023: a six-year retrospective study","volume":"10","author":"Gebremariam","year":"2024","journal-title":"Trop Diseases Travel Med Vaccines"},{"issue":"7","key":"10.1016\/j.jctube.2025.100528_b0170","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1473-3099(20)30919-1","article-title":"Quantifying the global number of tuberculosis survivors: a modelling study","volume":"21","author":"Dodd","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12889-023-17495-6","article-title":"Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021","volume":"24","author":"Bai","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jctube.2025.100528_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4241-7","article-title":"Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia","volume":"19","author":"Sinshaw","year":"2019","journal-title":"BMC infectious diseases"},{"key":"10.1016\/j.jctube.2025.100528_b0185","doi-asserted-by":"crossref","unstructured":"Dejene TA, Hailu GG, Kahsay AG, Wasihun AG. Mycobacterium tuberculosis and rifampicin-resistant tuberculosis among tuberculosis presumptive patients in selected zones of Tigray, Northern Ethiopia, 2016\u20132019. Heliyon. 2024;10(13).","DOI":"10.1016\/j.heliyon.2024.e33863"},{"issue":"11","key":"10.1016\/j.jctube.2025.100528_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240361","article-title":"Frequency of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: a cross sectional study","volume":"15","author":"Wasihun","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2025.100528_b0195","doi-asserted-by":"crossref","unstructured":"Abay G, Hailay B. Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia. 2020.","DOI":"10.21203\/rs.2.21744\/v2"},{"key":"10.1016\/j.jctube.2025.100528_b0200","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.2147\/IDR.S327607","article-title":"The magnitude of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia","author":"Diriba","year":"2021","journal-title":"Infect Drug Resist."},{"issue":"9","key":"10.1016\/j.jctube.2025.100528_b0205","first-page":"1","article-title":"Trend and associated factors of Mycobacterium tuberculosis and rifampicin resistance in southwest Ethiopia: institutional based retrospective study","volume":"15","author":"Haile","year":"2021","journal-title":"HealthSci J"},{"key":"10.1016\/j.jctube.2025.100528_b0210","article-title":"Prevalence of Mycobacterium tuberculosis infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare General Hospital","volume":"9","author":"Andarge","year":"2021","journal-title":"Southern Ethiopia SAGE open medicine"},{"key":"10.1016\/j.jctube.2025.100528_b0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jctube.2018.06.002","article-title":"Xpert MTB\/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high human immunodeficiency virus setting in gambella regional state, southwest ethiopia","volume":"12","author":"Ejeta","year":"2018","journal-title":"J Clin Tuberculosis Other Mycobacterial Diseases"},{"key":"10.1016\/j.jctube.2025.100528_b0220","doi-asserted-by":"crossref","unstructured":"Gebremedhn Bizayen Gebrehiwet GBG, Atsebaha Gebrekidan Kahsay AGK, Letemichael Negash Welekidan LNW, Amlsha Kahsay Hagos AKH, Getahun Kahsay Abay GKA, Dawit Gebreegziabiher Hagos DGH. Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti Hospital, Afar, Ethiopia. 2019.","DOI":"10.3855\/jidc.10462"},{"key":"10.1016\/j.jctube.2025.100528_b0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijregi.2022.09.001","article-title":"Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert\u00ae MTB\/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021","volume":"5","author":"Diriba","year":"2022","journal-title":"IJID regions"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.25259\/JPATS_25_2022","article-title":"Trends of Xpert MTB\/RIF in the diagnosis of Mycobacterium tuberculosis and rifampicin resistance in Southwest Nigeria: A 4-year retrospective study","volume":"4","author":"Alao","year":"2023","journal-title":"J Pan African Thoracic Soc"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0235","first-page":"47","article-title":"Incidence of rifampicin-resistance presumptive M. Tuberculosis cases among outpatients in Kebbi State, Nigeria. African","volume":"15","author":"Danlami","year":"2021","journal-title":"J Infect Diseases"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0240","article-title":"Prevalence of rifampicin resistance tuberculosis among HIV\/TB coinfected patients in Benue State Nigeria","volume":"38","author":"Ejeh","year":"2021","journal-title":"Pan African Med J"},{"issue":"8","key":"10.1016\/j.jctube.2025.100528_b0245","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/cid\/ciy1105","article-title":"Prevalence, predictors, and successful treatment outcomes of xpert MTB\/RIF\u2013identified rifampicin-resistant tuberculosis in post-conflict eastern democratic republic of the Congo, 2012\u20132017: a retrospective province-wide cohort study","volume":"69","author":"Bulabula","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jctube.2025.100528_b0250","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s15010-022-01941-5","article-title":"Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa","volume":"51","author":"Abdul","year":"2023","journal-title":"Infection"},{"issue":"20","key":"10.1016\/j.jctube.2025.100528_b0255","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.3390\/diagnostics13203253","article-title":"More than a decade of GeneXpert\u00ae mycobacterium tuberculosis\/rifampicin (ultra) testing in South Africa: laboratory insights from twenty-three million Tests","volume":"13","author":"da Silva","year":"2023","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.jctube.2025.100528_b0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5588\/pha.15.0001","article-title":"Countrywide roll-out of Xpert\u00ae MTB\/RIF in Swaziland: the first three years of implementation","volume":"5","author":"Sikhondze","year":"2015","journal-title":"Public Health Action"},{"issue":"2","key":"10.1016\/j.jctube.2025.100528_b0265","first-page":"1","article-title":"Multi-drug resistant Mycobacterium tuberculosis in port harcourt, Nigeria","volume":"7","author":"Otokunefor","year":"2018","journal-title":"Afr J Laborat Med"},{"key":"10.1016\/j.jctube.2025.100528_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-481","article-title":"Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert\u00ae MTB\/RIF in Kampala, Uganda: a retrospective study","volume":"14","author":"Mboowa","year":"2014","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.jctube.2025.100528_b0275","doi-asserted-by":"crossref","unstructured":"Addisu T, Tilahun M, Wedajo S, Sharew B. Trends Analysis of HIV Infection and Antiretroviral Treatment Outcome in Amhara Regional from 2015 to 2021, Northeast Ethiopia. HIV\/AIDS-Research and Palliative Care. 2023:399-410.","DOI":"10.2147\/HIV.S411235"},{"issue":"12","key":"10.1016\/j.jctube.2025.100528_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226507","article-title":"Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis","volume":"14","author":"Chaves Torres","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2025.100528_b0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.11604\/pamj.2024.47.149.35719","article-title":"Predictors of tuberculosis treatment outcomes among people living with HIV in some States in Nigeria","volume":"47","author":"Olajide","year":"2024","journal-title":"Pan Afr Med J"},{"issue":"5","key":"10.1016\/j.jctube.2025.100528_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002714","article-title":"Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes","volume":"4","author":"Geiger","year":"2024","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.jctube.2025.100528_b0295","first-page":"1","article-title":"Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis","volume":"19","author":"Van Hout","year":"2019","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.jctube.2025.100528_b0300","unstructured":"Federal Democratic Republic of Ethiopia MoH. GUIDELINES FOR MANAGEMENT OF TB, DR-TB AND LEPROSY IN ETHIOPIA, Addis Ababa Federal Democratic Republic of Ethiopia, Ministry of Health. 6th, November, 2017."},{"key":"10.1016\/j.jctube.2025.100528_b0305","doi-asserted-by":"crossref","unstructured":"Bedaso MH, Kalil FS. Trends of drug resistance tuberculosis from 2014 to 2018, Bale zone, Oromia region, Ethiopia. Infection and Drug Resistance. 2021:2073-8.","DOI":"10.2147\/IDR.S300723"},{"issue":"9","key":"10.1016\/j.jctube.2025.100528_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185105","article-title":"Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"12","author":"Musa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2025.100528_b0315","article-title":"Global tuberculosis report 2021: supplementary material: World Health","author":"Organization","year":"2022","journal-title":"Organization"},{"issue":"7","key":"10.1016\/j.jctube.2025.100528_b0320","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1473-3099(18)30222-6","article-title":"Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey","volume":"18","author":"Ismail","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"10.1016\/j.jctube.2025.100528_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200632","article-title":"Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa","volume":"13","author":"Chihota","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jctube.2025.100528_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154571","article-title":"Mapping of Mycobacterium tuberculosis complex genetic diversity profiles in Tanzania and other African countries","volume":"11","author":"Mbugi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2025.100528_b0335","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.2147\/IDR.S429001","article-title":"Mycobacterium tuberculosis Sub-Lineage 4.2. 2\/SIT149 as dominant drug-resistant clade in northwest Ethiopia 2020\u20132022: In-silico whole-genome sequence analysis","author":"Mekonnen","year":"2023","journal-title":"Infection and Drug Resistance"},{"key":"10.1016\/j.jctube.2025.100528_b0340","doi-asserted-by":"crossref","unstructured":"Abebaw Kebede AK, Dereje Beyene DB, Bazezew Yenew BY, Getu Diriba GD, Zemedu Mehamd ZM, Ayinalem Alemu AA, et al. Monitoring quality indicators for the Xpert MTB\/RIF molecular assay in Ethiopia. 2019.","DOI":"10.1371\/journal.pone.0225205"},{"key":"10.1016\/j.jctube.2025.100528_b0345","doi-asserted-by":"crossref","unstructured":"Zignol M, Gemert Wv, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bulletin of the world Health Organization. 2012;90:111-9.","DOI":"10.2471\/BLT.11.092585"},{"issue":"6","key":"10.1016\/j.jctube.2025.100528_b0350","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03300-2020","article-title":"World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update","volume":"57","author":"Mirzayev","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.jctube.2025.100528_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183237","article-title":"Peripheral clinic versus centralized laboratory-based Xpert MTB\/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana","volume":"12","author":"Agizew","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jctube.2025.100528_b0360","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/tmi.13205","article-title":"Low prevalence of MDR\u2010TB in Lao PDR: results from the first national anti\u2010tuberculosis drug resistance survey","volume":"24","author":"Iem","year":"2019","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0365","article-title":"Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case\u2013control study","volume":"11","author":"Zereabruk","year":"2024","journal-title":"BMJ OpenRespir Res"},{"key":"10.1016\/j.jctube.2025.100528_b0370","unstructured":"Ababa A. Implementation Guideline for GeneXpert MTB\/RIF Assay in Ethiopia. 2014."},{"issue":"12","key":"10.1016\/j.jctube.2025.100528_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144656","article-title":"Implementing the Xpert\u00ae MTB\/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries","volume":"10","author":"Ardizzoni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2025.100528_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-2","article-title":"Results from early programmatic implementation of Xpert MTB\/RIF testing in nine countries","volume":"14","author":"Creswell","year":"2014","journal-title":"BMC Infectious Diseases"},{"issue":"2","key":"10.1016\/j.jctube.2025.100528_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089301","article-title":"Feasibility of decentralised deployment of Xpert MTB\/RIF test at lower level of health system in India","volume":"9","author":"Raizada","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0390","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/s12879-024-09684-4","article-title":"Analysis of unsuccessful tests and the effect of prolonged clinical sample preprocessing in the GeneXpert MTB\/RIF assay","volume":"24","author":"Wei","year":"2024","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"10.1016\/j.jctube.2025.100528_b0395","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1088\/0004-637X\/715\/1\/277","article-title":"Insights into the Cepheid distance scale","volume":"715","author":"Bono","year":"2010","journal-title":"Astrophys J"},{"key":"10.1016\/j.jctube.2025.100528_b0400","unstructured":"Organization WH. Xpert MTB\/RIF implementation manual: technical and operational \u2018how-to\u2019; practical considerations. World Health Organization; 2014. Report No.: 9241506709."}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579425000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T07:21:28Z","timestamp":1754119288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579425000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":80,"alternative-id":["S2405579425000191"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100528","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifampicin-resistant Mycobacterium tuberculosis and unsuccessful results from Xpert\u00ae MTB\/Rif-Ultra assay in Amhara Region, Ethiopia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2025.100528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100528"}}